Avantor, Inc.
SEC CIK 1722482 · AVTR · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mehra Sanjeev K | Director | filed 2025 - 2026 |
| Summe Gregory L | Director | filed 2020 - 2026 |
| Lucier Gregory T | Director | filed 2025 - 2026 |
| Massaro Joseph R | Director | filed 2021 - 2026 |
| Severino Michael | Director | filed 2020 - 2026 |
| Murthy Mala | Director | filed 2021 - 2026 |
| Makin Louise | Director | filed 2024 - 2026 |
| Dingemans Simon | Director | filed 2026 - 2026 |
| Ligner Emmanuel | Director · President and CEO | filed 2025 - 2026 |
| Stubblefield Michael | Director · President and CEO | filed 2019 - 2025 |
| Peacock Jonathan M | Director | filed 2019 - 2025 |
| Andres Juan | Director | filed 2019 - 2025 |
| Kang Lan | Director | filed 2021 - 2025 |
| Carethers John | Director | filed 2021 - 2025 |
| Shaw Christi | Director | filed 2019 - 2023 |
| Holt Matthew S. | Director | filed 2019 - 2022 |
| Gupta Rajiv | Director | filed 2019 - 2022 |
| Natauri Jo | Director | filed 2019 - 2021 |
| Connolly Thomas | Director | filed 2019 - 2021 |
| Sachdev Rakesh | Director | filed 2019 - 2021 |
| Moura Andre V. | Director | filed 2019 - 2019 |
| Fine Robert | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Walker Corey | See Remarks | filed 2019 - 2026 |
| Brellier Ludovic | EVP, Bioscience & Medtech | filed 2026 - 2026 |
| Eck Steven W | SVP & Chief Accounting Officer | filed 2019 - 2026 |
| Jones R. Brent | EVP, Chief Financial Officer | filed 2023 - 2026 |
| Sokenu Claudius | EVP, Chief Legal & Compliance | filed 2023 - 2026 |
| Hankamer Brittany | EVP, Chief HR Officer | filed 2023 - 2026 |
| Gourdier Benoit | EVP, Bioscience Production | filed 2023 - 2026 |
| Blenn Mary | EVP, Chief Operating Officer | filed 2025 - 2026 |
| Couturier Christophe | See Remarks | filed 2019 - 2025 |
| Bramwell James | EVP, Strategic Partners | filed 2019 - 2025 |
| Sahin Kitty | EVP, Strategy&Corp Development | filed 2023 - 2024 |
| Stone Randy Lee | EVP, Proprietary Products | filed 2023 - 2024 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | filed 2021 - 2024 |
| Vanderhaegen Frederic | EVP, Europe | filed 2019 - 2023 |
| Szlosek Thomas A | EVP and CFO | filed 2019 - 2023 |
| Brophy Gerard | EVP, Biopharma Production | filed 2019 - 2023 |
| Miller Justin | EVP, Gen. Counsel & Secretary | filed 2019 - 2023 |
| Henson Meghan | EVP, Chief HR Officer | filed 2021 - 2023 |
| Wondrasch Michael | EVP, CIO | filed 2019 - 2023 |
| Murray Mark Christopher | EVP, Biomaterials & AT | filed 2020 - 2022 |
| Ohri Devashish | EVP, IMEA | filed 2019 - 2021 |
| Henrichwark Sven | EVP, APAC Region | filed 2020 - 2021 |
| Mcallister Eric | See Remarks | filed 2019 - 2020 |
| Foxe Tanya | EVP, Operations & Supply Chain | filed 2019 - 2020 |
| Hofman Bjorn | EVP and COO | filed 2019 - 2019 |
| Kulkarni Ashish | See Remarks | filed 2019 - 2019 |
| Depetris Michael | SVP and Corporate Controller | filed 2019 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.